TrialBMC nephrology2018

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).

Taketsugu Hama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.